NCT04658394 is a NA clinical trial of Reminiscence therapy in Dementia, sponsored by Rsocialform - Geriatria, Lda.

Who is sponsoring NCT04658394?

NCT04658394 is sponsored by Rsocialform - Geriatria, Lda.

What drugs are being tested in NCT04658394?

Interventions in NCT04658394: Reminiscence therapy.

What condition does NCT04658394 study?

NCT04658394 studies Dementia, Neurocognitive Disorders, Cognitive Impairment, Cognitive Dysfunction, Cognitive Decline.

Is NCT04658394 still recruiting?

NCT04658394 is currently completed. Last updated 1 September 2021.

Last reviewed 2021-09-01 · How we verify

NCT04658394

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Individual Reminiscence Therapy in the Elderly People With Neurocognitive Disorders

Completed NA Last updated 1 September 2021

What this trial tests

NA trial testing Reminiscence therapy in Dementia in 122 participants. Completed in 31 August 2021.

Timeline

11 February 2021

Primary endpoint
31 August 2021

31 August 2021

Quick facts

Lead sponsor	Rsocialform - Geriatria, Lda
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	122
Start date	11 February 2021
Primary completion	31 August 2021
Estimated completion	31 August 2021
Sites	13 locations across Portugal

Drugs / interventions tested

Reminiscence therapy

Conditions studied

Dementia — all drugs for Dementia →
Neurocognitive Disorders — all drugs for Neurocognitive Disorders →
Cognitive Impairment — all drugs for Cognitive Impairment →
Cognitive Dysfunction — all drugs for Cognitive Dysfunction →

Sponsor

Rsocialform - Geriatria, Lda

Who can join

65 and older, any sex, with Dementia or Neurocognitive Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research aims to evaluate the ability of individual reminiscence therapy (RT), using a simple reminiscence format, to improve the overall cognitive function, memory, emotional status and quality of life (QoL) of older adults with neurocognitive disorders (NCD) attending social care and support services. A multicentre randomised controlled trial (RCT) is proposed in Azores archipelago with repeated measures (pre-intervention, post-intervention and follow-up). Intervention group will hold 26 individual RT sessions, twice a week for 13 weeks. Control group participants will maintain their treatment as usual. Make a subsample analysis of the main clinical diagnoses, and compare the results of sample and subsample with a previous study that had the same intervention protocol.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effectiveness of a Randomized Controlled Trial of Individual Reminiscence Therapy on Cognition, Mood and Quality of Life in Azorean Older Adults with Neurocognitive Disorders.
Justo-Henriques SI, Pérez-Sáez E, Apóstolo JLA, Carvalho JO. · · 2021 · cited 8× · PMID 34830677 · DOI 10.3390/jcm10225395

Verify or expand the search:

Other trials of Reminiscence therapy

Trials testing the same drug.

NCT06964399 — The Effect of Reminiscence Therapy in Elderly · NA · recruiting
NCT06812442 — Effectiveness of a 3-month Individual Reminiscence Therapy Program in Older Adults With Alzheimer's Disease · NA · completed
NCT06180694 — Reminiscence Therapy in Individuals With Dementia · NA · completed
NCT07374887 — Impact of Snoezelen Intervention and Reminiscence Therapy on Seniors' Emotionality and Anxiety · NA · completed
NCT05637177 — Preventive Intervention to Promote Healthy Ageing · NA · completed

Other recruiting trials for Dementia

Currently open trials in the same condition.

NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
NCT06088810 — The Impact of Music Intervention on Sleep · NA · recruiting
NCT07482800 — Dementia in Fiction and Clinical Narratives · recruiting
NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home · NA · recruiting

Other Rsocialform - Geriatria, Lda trials

Trials by the same sponsor.

NCT07041008 — Cognitive Stimulation in Older Adults With Alzheimer's Disease · NA · completed
NCT06812442 — Effectiveness of a 3-month Individual Reminiscence Therapy Program in Older Adults With Alzheimer's Disease · NA · completed
NCT05433493 — Effect of Individual Cognitive Stimulation on Memory and Executive Function in Older Adults With Alzheimer's Disease · NA · completed
NCT05379426 — Older Adults' Perceptions of the Impact COVID-19 Pandemic · completed
NCT04180683 — Comparison Study of the Different Abbreviated Versions of the Geriatric Depression Scale · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04658394 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rsocialform - Geriatria, Lda
Last refreshed: 1 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04658394.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing